During the past decade, Queen Elizabeth University Hospital Campus conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Queen Elizabeth University Hospital Campus" are "Alzheimer's Disease" (1 trials), "Calcific Uremic Arteriolopathy" (1 trials) and "Calciphylaxis" (1 trials). Many other conditions were trialed in "Queen Elizabeth University Hospital Campus" in a lesser frequency.

Most popular intervention types in "Queen Elizabeth University Hospital Campus" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Aducanumab" (1 trials), "Experimatenl SNF472 (Open-label)" (1 trials), "Experimental: SNF472" (1 trials) and "Placebo Comparator: Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Queen Elizabeth University Hospital Campus" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Queen Elizabeth University Hospital Campus". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Queen Elizabeth University Hospital Campus, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Queen Elizabeth University Hospital Campus, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".